why choose us

First received: August 19, 2022

Clinical Trial: A Survey of Icatibant in Pediatric Participants With Hereditary Angioedema

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hereditary Angioedema (HAE)

Study Type: OBSERVATIONAL


Official Title: Specified Drug Use Surveillance of FIRAZYR Subcutaneous Injection 30mg Syringe for Pediatric Subjects With Hereditary Angioedema (All-Case Investigation)

Brief Summary: This study is a survey in Japan of Icatibant subcutaneous injection 30 mg syringe used to treat children or teenagers with acute attacks of hereditary angioedema (HAE).The study sponsor will not be involved in how the participants are treated but will provide instructions on how the clinics will record what happens during the study.The main aim of the study is to check for side effects related from Icatibant subcutaneous injection 30 mg syringe and to check if Icatibant subcutaneous injection 30 mg syringe…

Read more